Tag: inflammatory bowel disease treatment industry

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What CAGR Is Anticipated for the Inflammatory Bowel Disease Treatment Market Through 2029?

In recent years, the market size for the treatment of inflammatory bowel disease has witnessed a robust growth. This market is forecasted to expand from $25.26 billion in 2024 to $27.19 billion in 2025, showcasing a compound annual growth rate (CAGR) of 7.6%. The upturn during the historical period can be credited to factors such as the increasing occurrence of inflammatory bowel disease, growing preference for biologics and immunomodulators, advancements in treatment methodology, an escalating older population, and a heightened consciousness about the disease.

In the coming years, the market for inflammatory bowel disease (IBD) treatment is projected to experience significant growth, with potential to reach “$39.39 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%.” Factors driving this projected growth include increased investment in R&D efforts, higher demand for biosimilars, an increasing prevalence of IBD in developing markets, the rising need for tailor-made medicine, and the incorporation of precision medicine in IBD care. A rise in product introductions and approvals, individualized dosage and treatment strategies in managing IBD, the application of telemedicine in remotely tracking IBD patients, the investigation of microbiome-oriented therapies for IBD, and the implementation of value-based care models in IBD management are also potential trends for the forecast period.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6704&type=smp

What Market Forces Are Driving The Inflammatory Bowel Disease Treatment Sector In 2025 And Beyond?

The inflammatory bowel disease treatment market is witnessing significant growth due to the increasing incidence of Crohn’s disease and ulcerative colitis. These disorders, both subtypes of inflammatory bowel disease (IBD), cause inflammation and sores or ulcers in the digestive tract. The increasing instances of these conditions are set to heighten demand for treatments designed to alleviate bowel inflammation and curb potential medical complications. March 2022 research sourced from the United States National Library of Medicine, a medical library based in the US, indicates that approximately 1.6 million Americans are presently living with an inflammatory bowel disease (either Crohn’s disease or ulcerative colitis). Also, about 70,000 fresh IBD cases are identified annually within the US. Therefore, the escalating occurrence of Crohn’s disease and ulcerative colitis will likely fuel the growth of the inflammatory bowel disease treatment market.

How Is The Global Inflammatory Bowel Disease Treatment Market Categorized By Segments?

The inflammatory bowel disease treatment market covered in this report is segmented –

1) By Drug Class: Aminosalicylates, Corticosteroids, TNF inhibitors, IL inhibitors, Anti-integrin, JAK inhibitors, Other Drug Classes

2) By Type: Crohn’s Disease, Ulcerative Colitis

3) By Route Of Administration: Oral, Injectable

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Aminosalicylates: Mesalamine, Sulfasalazine, Balsalazide

2) By Corticosteroids: Prednisone, Budesonide, Hydrocortisone

3) By TNF Inhibitors: Infliximab, Adalimumab, Certolizumab pegol

4) By IL Inhibitors: Ustekinumab, Guselkumab

5) By Anti-Integrin: Vedolizumab, Natalizumab

6) By JAK Inhibitors: Tofacitinib, Filgotinib

7) By Other Drug Classes: Antibiotics, Immunosuppressants, Other Novel Therapies

What Trends Are Currently Influencing Growth In The Inflammatory Bowel Disease Treatment Market?

The rise of technology is a significant emerging trend in the treatment market for inflammatory bowel disease. Numerous major firms within the sector are increasingly leveraging AI-centric registries to gain a competitive advantage. For example, Verantos, an RWE firm based in California, launched the Inflammatory Bowel Disease Pragmatic Registry in May 2024, which employs cutting-edge AI to yield high-caliber real-world evidence (RWE) for ulcerative colitis and Crohn’s disease. The purpose of this registry is to aid in the creation of effective treatments by providing a robust dataset, with over 3 billion data points on patient care. This tool assists biopharmaceutical researchers with deep understanding into disease severity, the efficacy of treatments, and clinical outcomes by capitalizing on both structured and unstructured data sourced from electronic health records.

Which Firms Are Considered Leaders In The Inflammatory Bowel Disease Treatment Market Space?

Major companies operating in the inflammatory bowel disease treatment market include AbbVie Inc., Biogen Inc., Johnson & Johnson, Amgen Inc., Advanced Gastroenterology and Surgery Associates P. A., Atlanta Gastroenterology Associates LLC, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Cedars-Sinai Medical Center, Celgene Corporation, Cleveland Clinic Foundation, Digestive Disease Associates of Rockland P. C., Eli Lilly and Company, Gastrointestinal Specialists Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Illinois Gastroenterology Group LLC, The Johns Hopkins Hospital Inc., Massachusetts General Hospital, Mayo Clinic, Merck & Co. Inc., Mount Sinai Health System Inc., Novartis International AG, Pfizer Inc., F. Hoffmann-La Roche Ltd, Takeda Pharmaceutical Company Limited, Texas Digestive Disease Consultants P. A., The Oregon Clinic – Gastroenterology West P. C., Salix Pharmaceuticals Inc., Vifor Pharma AG, Zydus Pharmaceuticals (USA) Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

What Role Do Regional Policies And Investments Play In Inflammatory Bowel Disease Treatment Market Expansion?

North America was the largest region in the inflammatory bowel disease treatment market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inflammatory bowel disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=6704&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What CAGR Is Anticipated for the Inflammatory Bowel Disease Treatment Market Through 2029?

In recent years, the market size for the treatment of inflammatory bowel disease has witnessed a robust growth. This market is forecasted to expand from $25.26 billion in 2024 to $27.19 billion in 2025, showcasing a compound annual growth rate (CAGR) of 7.6%. The upturn during the historical period can be credited to factors such as the increasing occurrence of inflammatory bowel disease, growing preference for biologics and immunomodulators, advancements in treatment methodology, an escalating older population, and a heightened consciousness about the disease.

In the coming years, the market for inflammatory bowel disease (IBD) treatment is projected to experience significant growth, with potential to reach “$39.39 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%.” Factors driving this projected growth include increased investment in R&D efforts, higher demand for biosimilars, an increasing prevalence of IBD in developing markets, the rising need for tailor-made medicine, and the incorporation of precision medicine in IBD care. A rise in product introductions and approvals, individualized dosage and treatment strategies in managing IBD, the application of telemedicine in remotely tracking IBD patients, the investigation of microbiome-oriented therapies for IBD, and the implementation of value-based care models in IBD management are also potential trends for the forecast period.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6704&type=smp

What Market Forces Are Driving The Inflammatory Bowel Disease Treatment Sector In 2025 And Beyond?

The inflammatory bowel disease treatment market is witnessing significant growth due to the increasing incidence of Crohn’s disease and ulcerative colitis. These disorders, both subtypes of inflammatory bowel disease (IBD), cause inflammation and sores or ulcers in the digestive tract. The increasing instances of these conditions are set to heighten demand for treatments designed to alleviate bowel inflammation and curb potential medical complications. March 2022 research sourced from the United States National Library of Medicine, a medical library based in the US, indicates that approximately 1.6 million Americans are presently living with an inflammatory bowel disease (either Crohn’s disease or ulcerative colitis). Also, about 70,000 fresh IBD cases are identified annually within the US. Therefore, the escalating occurrence of Crohn’s disease and ulcerative colitis will likely fuel the growth of the inflammatory bowel disease treatment market.

How Is The Global Inflammatory Bowel Disease Treatment Market Categorized By Segments?

The inflammatory bowel disease treatment market covered in this report is segmented –

1) By Drug Class: Aminosalicylates, Corticosteroids, TNF inhibitors, IL inhibitors, Anti-integrin, JAK inhibitors, Other Drug Classes

2) By Type: Crohn’s Disease, Ulcerative Colitis

3) By Route Of Administration: Oral, Injectable

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Aminosalicylates: Mesalamine, Sulfasalazine, Balsalazide

2) By Corticosteroids: Prednisone, Budesonide, Hydrocortisone

3) By TNF Inhibitors: Infliximab, Adalimumab, Certolizumab pegol

4) By IL Inhibitors: Ustekinumab, Guselkumab

5) By Anti-Integrin: Vedolizumab, Natalizumab

6) By JAK Inhibitors: Tofacitinib, Filgotinib

7) By Other Drug Classes: Antibiotics, Immunosuppressants, Other Novel Therapies

What Trends Are Currently Influencing Growth In The Inflammatory Bowel Disease Treatment Market?

The rise of technology is a significant emerging trend in the treatment market for inflammatory bowel disease. Numerous major firms within the sector are increasingly leveraging AI-centric registries to gain a competitive advantage. For example, Verantos, an RWE firm based in California, launched the Inflammatory Bowel Disease Pragmatic Registry in May 2024, which employs cutting-edge AI to yield high-caliber real-world evidence (RWE) for ulcerative colitis and Crohn’s disease. The purpose of this registry is to aid in the creation of effective treatments by providing a robust dataset, with over 3 billion data points on patient care. This tool assists biopharmaceutical researchers with deep understanding into disease severity, the efficacy of treatments, and clinical outcomes by capitalizing on both structured and unstructured data sourced from electronic health records.

Which Firms Are Considered Leaders In The Inflammatory Bowel Disease Treatment Market Space?

Major companies operating in the inflammatory bowel disease treatment market include AbbVie Inc., Biogen Inc., Johnson & Johnson, Amgen Inc., Advanced Gastroenterology and Surgery Associates P. A., Atlanta Gastroenterology Associates LLC, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Cedars-Sinai Medical Center, Celgene Corporation, Cleveland Clinic Foundation, Digestive Disease Associates of Rockland P. C., Eli Lilly and Company, Gastrointestinal Specialists Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Illinois Gastroenterology Group LLC, The Johns Hopkins Hospital Inc., Massachusetts General Hospital, Mayo Clinic, Merck & Co. Inc., Mount Sinai Health System Inc., Novartis International AG, Pfizer Inc., F. Hoffmann-La Roche Ltd, Takeda Pharmaceutical Company Limited, Texas Digestive Disease Consultants P. A., The Oregon Clinic – Gastroenterology West P. C., Salix Pharmaceuticals Inc., Vifor Pharma AG, Zydus Pharmaceuticals (USA) Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

What Role Do Regional Policies And Investments Play In Inflammatory Bowel Disease Treatment Market Expansion?

North America was the largest region in the inflammatory bowel disease treatment market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inflammatory bowel disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=6704&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What CAGR Is Anticipated for the Inflammatory Bowel Disease Treatment Market Through 2029?

In recent years, the market size for the treatment of inflammatory bowel disease has witnessed a robust growth. This market is forecasted to expand from $25.26 billion in 2024 to $27.19 billion in 2025, showcasing a compound annual growth rate (CAGR) of 7.6%. The upturn during the historical period can be credited to factors such as the increasing occurrence of inflammatory bowel disease, growing preference for biologics and immunomodulators, advancements in treatment methodology, an escalating older population, and a heightened consciousness about the disease.

In the coming years, the market for inflammatory bowel disease (IBD) treatment is projected to experience significant growth, with potential to reach “$39.39 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%.” Factors driving this projected growth include increased investment in R&D efforts, higher demand for biosimilars, an increasing prevalence of IBD in developing markets, the rising need for tailor-made medicine, and the incorporation of precision medicine in IBD care. A rise in product introductions and approvals, individualized dosage and treatment strategies in managing IBD, the application of telemedicine in remotely tracking IBD patients, the investigation of microbiome-oriented therapies for IBD, and the implementation of value-based care models in IBD management are also potential trends for the forecast period.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6704&type=smp

What Market Forces Are Driving The Inflammatory Bowel Disease Treatment Sector In 2025 And Beyond?

The inflammatory bowel disease treatment market is witnessing significant growth due to the increasing incidence of Crohn’s disease and ulcerative colitis. These disorders, both subtypes of inflammatory bowel disease (IBD), cause inflammation and sores or ulcers in the digestive tract. The increasing instances of these conditions are set to heighten demand for treatments designed to alleviate bowel inflammation and curb potential medical complications. March 2022 research sourced from the United States National Library of Medicine, a medical library based in the US, indicates that approximately 1.6 million Americans are presently living with an inflammatory bowel disease (either Crohn’s disease or ulcerative colitis). Also, about 70,000 fresh IBD cases are identified annually within the US. Therefore, the escalating occurrence of Crohn’s disease and ulcerative colitis will likely fuel the growth of the inflammatory bowel disease treatment market.

How Is The Global Inflammatory Bowel Disease Treatment Market Categorized By Segments?

The inflammatory bowel disease treatment market covered in this report is segmented –

1) By Drug Class: Aminosalicylates, Corticosteroids, TNF inhibitors, IL inhibitors, Anti-integrin, JAK inhibitors, Other Drug Classes

2) By Type: Crohn’s Disease, Ulcerative Colitis

3) By Route Of Administration: Oral, Injectable

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Aminosalicylates: Mesalamine, Sulfasalazine, Balsalazide

2) By Corticosteroids: Prednisone, Budesonide, Hydrocortisone

3) By TNF Inhibitors: Infliximab, Adalimumab, Certolizumab pegol

4) By IL Inhibitors: Ustekinumab, Guselkumab

5) By Anti-Integrin: Vedolizumab, Natalizumab

6) By JAK Inhibitors: Tofacitinib, Filgotinib

7) By Other Drug Classes: Antibiotics, Immunosuppressants, Other Novel Therapies

What Trends Are Currently Influencing Growth In The Inflammatory Bowel Disease Treatment Market?

The rise of technology is a significant emerging trend in the treatment market for inflammatory bowel disease. Numerous major firms within the sector are increasingly leveraging AI-centric registries to gain a competitive advantage. For example, Verantos, an RWE firm based in California, launched the Inflammatory Bowel Disease Pragmatic Registry in May 2024, which employs cutting-edge AI to yield high-caliber real-world evidence (RWE) for ulcerative colitis and Crohn’s disease. The purpose of this registry is to aid in the creation of effective treatments by providing a robust dataset, with over 3 billion data points on patient care. This tool assists biopharmaceutical researchers with deep understanding into disease severity, the efficacy of treatments, and clinical outcomes by capitalizing on both structured and unstructured data sourced from electronic health records.

Which Firms Are Considered Leaders In The Inflammatory Bowel Disease Treatment Market Space?

Major companies operating in the inflammatory bowel disease treatment market include AbbVie Inc., Biogen Inc., Johnson & Johnson, Amgen Inc., Advanced Gastroenterology and Surgery Associates P. A., Atlanta Gastroenterology Associates LLC, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Cedars-Sinai Medical Center, Celgene Corporation, Cleveland Clinic Foundation, Digestive Disease Associates of Rockland P. C., Eli Lilly and Company, Gastrointestinal Specialists Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Illinois Gastroenterology Group LLC, The Johns Hopkins Hospital Inc., Massachusetts General Hospital, Mayo Clinic, Merck & Co. Inc., Mount Sinai Health System Inc., Novartis International AG, Pfizer Inc., F. Hoffmann-La Roche Ltd, Takeda Pharmaceutical Company Limited, Texas Digestive Disease Consultants P. A., The Oregon Clinic – Gastroenterology West P. C., Salix Pharmaceuticals Inc., Vifor Pharma AG, Zydus Pharmaceuticals (USA) Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

What Role Do Regional Policies And Investments Play In Inflammatory Bowel Disease Treatment Market Expansion?

North America was the largest region in the inflammatory bowel disease treatment market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inflammatory bowel disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=6704&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only._x000D_

_x000D_

#What CAGR Is Anticipated for the Inflammatory Bowel Disease Treatment Market Through 2029?#_x000D_

The market size of treatment for inflammatory bowel disease has seen robust growth in the past few years. It is projected to escalate from $25.26 billion in 2024 to $27.19 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.6%. Factors such as higher incidence of inflammatory bowel disease, a growing interest in biologics and immunomodulators, innovation in treatment methods, an aging population, and heightened knowledge about the disease have all contributed to this historical growth._x000D_

_x000D_

In the coming years, the market for the treatment of inflammatory bowel disease is predicted to experience substantial growth, with an expectation to reach a value of $39.39 billion by 2029, growing at a yearly compound rate of 9.7%. This anticipated growth during the forecast period can be linked to increasing investments in research and development, a growing demand for biosimilars, higher incidence of inflammatory bowel disease in emerging markets, increased demand for tailor-made medicine, and the incorporation of precision medicine into treating IBD. Further trends set to mark the forecast period include a boost in product releases and approvals, bespoke dosing and treatment plans for managing IBD, the remote monitoring of IBD patients through telemedicine, the exploration of possible therapies for IBD based on microbiomes, and a move towards value-based care models in the treatment of IBD._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=6704&type=smp_x000D_

_x000D_

#What Market Forces Are Driving The Inflammatory Bowel Disease Treatment Sector In 2025 And Beyond?#_x000D_

The surge in cases of Crohn’s disease and ulcerative colitis is substantially propelling the growth of the market for inflammatory bowel disease treatments. Crohn’s disease and ulcerative colitis fall under the category of inflammatory bowel diseases (IBD) that trigger inflammation and form ulcers (sores) in the digestive system. The escalation in incidences of Crohn’s disease and ulcerative colitis is likely to amplify the demand for treatments for inflammatory bowel disease, as these medications are extensively employed to curb bowel inflammation and mitigate and avert medical complications. For example, research released in March 2022 by the US-based United States National Library of Medicine disclosed that approximately 1.6 million American citizens are presently afflicted with inflammatory bowel disease (Crohn’s disease or ulcerative colitis), and around 70,000 fresh cases of IBD are identified every year in the USA. Therefore, the escalating occurrence of Crohn’s disease and ulcerative colitis is projected to stimulate the growth of the market for treatments for inflammatory bowel disease._x000D_

_x000D_

#How Is The Global Inflammatory Bowel Disease Treatment Market Categorized By Segments?#_x000D_

The inflammatory bowel disease treatment market covered in this report is segmented – _x000D_

_x000D_

1) By Drug Class: Aminosalicylates, Corticosteroids, TNF inhibitors, IL inhibitors, Anti-integrin, JAK inhibitors, Other Drug Classes_x000D_

2) By Type: Crohn’s Disease, Ulcerative Colitis_x000D_

3) By Route Of Administration: Oral, Injectable_x000D_

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy_x000D_

_x000D_

Subsegments:_x000D_

1) By Aminosalicylates: Mesalamine, Sulfasalazine, Balsalazide_x000D_

2) By Corticosteroids: Prednisone, Budesonide, Hydrocortisone_x000D_

3) By TNF Inhibitors: Infliximab, Adalimumab, Certolizumab pegol_x000D_

4) By IL Inhibitors: Ustekinumab, Guselkumab_x000D_

5) By Anti-Integrin: Vedolizumab, Natalizumab_x000D_

6) By JAK Inhibitors: Tofacitinib, Filgotinib_x000D_

7) By Other Drug Classes: Antibiotics, Immunosuppressants, Other Novel Therapies_x000D_

_x000D_

_x000D_

#What Long-Term Trends Are Likely To Affect The Inflammatory Bowel Disease Treatment Market?#_x000D_

The growing trend of technological advancements is having a significant impact on the inflammatory bowel disease treatment market, with major companies turning their attention towards implementing AI-assisted registries in order to gain a competitive advantage. Verantos, a California-based real-world evidence (RWE) firm, exemplified this trend in May 2024 when they launched the Inflammatory Bowel Disease Pragmatic Registry which utilizes cutting-edge artificial intelligence to produce high-quality real-world evidence (RWE) pertinent to ulcerative colitis and Crohn’s disease. The registry is envisioned to assist the generation of successful therapies via a comprehensive dataset comprised of over 3 billion data points reflecting patient care. This allows biopharma researchers to garner in-depth understanding of disease severity, treatment efficacy and clinical outcomes through harnessing both structured and unstructured data derived from electronic health records._x000D_

_x000D_

#Which Firms Are Considered Leaders In The Inflammatory Bowel Disease Treatment Market Space?#_x000D_

Major companies operating in the inflammatory bowel disease treatment market include AbbVie Inc., Biogen Inc., Johnson & Johnson, Amgen Inc., Advanced Gastroenterology and Surgery Associates P. A., Atlanta Gastroenterology Associates LLC, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Cedars-Sinai Medical Center, Celgene Corporation, Cleveland Clinic Foundation, Digestive Disease Associates of Rockland P. C., Eli Lilly and Company, Gastrointestinal Specialists Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Illinois Gastroenterology Group LLC, The Johns Hopkins Hospital Inc., Massachusetts General Hospital, Mayo Clinic, Merck & Co. Inc., Mount Sinai Health System Inc., Novartis International AG, Pfizer Inc., F. Hoffmann-La Roche Ltd, Takeda Pharmaceutical Company Limited, Texas Digestive Disease Consultants P. A., The Oregon Clinic – Gastroenterology West P. C., Salix Pharmaceuticals Inc., Vifor Pharma AG, Zydus Pharmaceuticals (USA) Inc. _x000D_

_x000D_

#Get The Full Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report_x000D_

_x000D_

#What Role Do Regional Policies And Investments Play In Inflammatory Bowel Disease Treatment Market Expansion?#_x000D_

North America was the largest region in the inflammatory bowel disease treatment market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inflammatory bowel disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=6704&type=smp_x000D_

_x000D_

#About The Business Research Company:#_x000D_

_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Inflammatory Bowel Disease Treatment Market?

The market size of treatments for inflammatory bowel disease has witnessed robust growth in the past years. The value is set to increase from $25.26 billion in 2024 to $27.45 billion in 2025, with a compound annual growth rate (CAGR) of 8.6%. The growth observed during the historical period is due to factors such as a higher number of inflammatory bowel disease cases, a growing demand for biologics and immunomodulators, the development of improved treatment methods, an increase in the elderly population, and heightened public awareness about the disease.

What Growth Rate Is Forecasted for the Inflammatory Bowel Disease Treatment Market by 2029?

Predictions suggest the market size for the treatment of inflammatory bowel disease will observe a meteoric rise in the coming years. It’s forecasted that by 2029, it will climb to $40.27 billion, expanding at a compound annual growth rate (CAGR) of 10.1%. The growth throughout the projected period can be traced back to an upsurge in research and development activities, swelling demand for biosimilars, a higher frequency of inflammatory bowel disease in developing markets, a surge in personalized medicine demand, and the incorporation of precision medicine in IBD therapies. Noteworthy trends predicted during the forecast period consist of an increase in product introductions and approvals, personalized dosage and treatment regimens in IBD management, application of telemedicine for distantly monitoring IBD patients, investigation into microbiome-focused therapies for IBD, and the embracing of value-focused care models in IBD treatment.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6704&type=smp

Which Key Companies Are Shaping the Future of the Inflammatory Bowel Disease Treatment Market?

Major companies operating in the inflammatory bowel disease treatment market include AbbVie Inc., Biogen Inc., Johnson & Johnson, Amgen Inc., Advanced Gastroenterology and Surgery Associates P. A., Atlanta Gastroenterology Associates LLC, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Cedars-Sinai Medical Center, Celgene Corporation, Cleveland Clinic Foundation, Digestive Disease Associates of Rockland P. C., Eli Lilly and Company, Gastrointestinal Specialists Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Illinois Gastroenterology Group LLC, The Johns Hopkins Hospital Inc., Massachusetts General Hospital, Mayo Clinic, Merck & Co. Inc., Mount Sinai Health System Inc., Novartis International AG, Pfizer Inc., F. Hoffmann-La Roche Ltd, Takeda Pharmaceutical Company Limited, Texas Digestive Disease Consultants P. A., The Oregon Clinic – Gastroenterology West P. C., Salix Pharmaceuticals Inc., Vifor Pharma AG, Zydus Pharmaceuticals (USA) Inc.

Which Factors Are Driving Demand in the Inflammatory Bowel Disease Treatment Industry?

The escalating incidence of Crohn’s disease and ulcerative colitis is a significant factor propelling the inflammatory bowel disease treatment market. Crohn’s disease and ulcerative colitis are variants of inflammatory bowel diseases (IBD) which lead to inflammation and ulcers (sores) in the digestive tract. The growing instances of Crohn’s disease and ulcerative colitis are set to augment demand for inflammatory bowel disease treatments, known for their efficacy in reducing bowel inflammation and managing or staving off medical complications. For example, a research study published in the United States National Library of Medicine in March 2022 noted that approximately 1.6 million Americans are currently living with inflammatory bowel disease (either Crohn’s disease or ulcerative colitis). Furthermore, approximately 70,000 new IBD diagnoses are made annually in the USA. Consequently, the increasing incidence of Crohn’s disease and ulcerative colitis is likely to fuel the expansion of the inflammatory bowel disease treatment market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=6704&type=smp

How Is the Inflammatory Bowel Disease Treatment Market Segmented by Several Divisions?

The inflammatory bowel disease treatment market covered in this report is segmented –

1) By Drug Class: Aminosalicylates, Corticosteroids, TNF inhibitors, IL inhibitors, Anti-integrin, JAK inhibitors, Other Drug Classes

2) By Type: Crohn’s Disease, Ulcerative Colitis

3) By Route Of Administration: Oral, Injectable

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Aminosalicylates: Mesalamine, Sulfasalazine, Balsalazide

2) By Corticosteroids: Prednisone, Budesonide, Hydrocortisone

3) By TNF Inhibitors: Infliximab, Adalimumab, Certolizumab pegol

4) By IL Inhibitors: Ustekinumab, Guselkumab

5) By Anti-Integrin: Vedolizumab, Natalizumab

6) By JAK Inhibitors: Tofacitinib, Filgotinib

7) By Other Drug Classes: Antibiotics, Immunosuppressants, Other Novel Therapies

What are the Emerging Market Trends Driving the Growth of the Inflammatory Bowel Disease Treatment Industry?

Technological progression is a prominent trend that is increasingly popular in the inflammatory bowel disease treatment sector. Significant companies in the market are emphasizing the utilization of AI-driven registries to gain a competitive advantage. For example, Verantos, a company based in California that specializes in real-world evidence (RWE), introduced the Inflammatory Bowel Disease Pragmatic Registry in May 2024. This leverages advanced artificial intelligence to produce reliable, real-world evidence for ulcerative colitis and Crohn’s disease. The goal of the registry is to aid in the creation of effective therapies by offering a comprehensive dataset with over 3 billion data points related to patient care. This enables biopharmaceutical researchers to gain detailed understanding of disease severity, medication efficacy, and clinical results by using both structured and unstructured data collected from electronic health records.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

Which Regions Are Driving Growth in the Inflammatory Bowel Disease Treatment Market?

North America was the largest region in the inflammatory bowel disease treatment market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inflammatory bowel disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6704

This Report Delivers Insight On:

1. How big is the inflammatory bowel disease treatment market, and how is it changing globally?

2. Who are the major companies in the inflammatory bowel disease treatment market, and how are they performing?

3. What are the key opportunities and risks in the inflammatory bowel disease treatment market right now?

4. Which products or customer segments are growing the most in the inflammatory bowel disease treatment market?

5. What factors are helping or slowing down the growth of the inflammatory bowel disease treatment market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the inflammatory bowel disease treatment industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#How Has the Inflammatory Bowel Disease Treatment Market Growth Performance Trended Historically, And What Lies Ahead?

The market for treating inflammatory bowel disease has seen significant growth in recent years. It is projected to increase from a worth of $25.26 billion in 2024 to $27.45 billion in 2025, with a compound annual growth rate (CAGR) of 8.6%. This remarkable progress, observed historically, is due to a higher prevalence of inflammatory bowel disease, an escalating requirement for biologics and immunomodulators, advancements in therapeutic choices, an aging population, and heightened awareness about the condition.

The market size for the treatment of inflammatory bowel disease is projected to witness substantial growth in the forthcoming years, expanding to $40.27 billion in 2029 at a 10.1% compound annual growth rate (CAGR). The anticipated surge during the prediction period can be credited to the heightened investment in research and development activities, expanding demand for biosimilars, surging prevalence of inflammatory bowel disease in emerging markets, increasing demand for personalized medicine, and the incorporation of precision medicine in IBD therapies. Notable trends expected during this forecast period comprise an increase in the count of product launches and approvals, personalization in dosing and treatment plans for IBD management, the application of telemedicine for remotely monitoring IBD patients, study of microbiome-based treatments for IBD, and the adoption of value-based care models in the treatment of IBD.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6704&type=smp

What External and Internal Drivers Are Contributing to the Growth of theInflammatory Bowel Disease Treatment Market?

An increase in the number of Crohn’s disease and ulcerative colitis cases is a major contributing factor to the expansion of the inflammatory bowel disease treatment market. These diseases, which are both types of inflammatory bowel disorders, cause inflammation and ulcers in the digestive system. The increase in these diseases is predicted to escalate the need for inflammatory bowel disease therapies as they’re extensively utilized to mitigate bowel inflammation and prevent or reduce health complications. For example, research released in March 2022 by the United States National Library of Medicine, an American medical library, reveals that about 1.6 million Americans are currently living with inflammatory bowel disease (either Crohn’s disease or ulcerative colitis) and there are roughly 70,000 new IBD diagnoses in the USA annually. Therefore, the growing occurrence of Crohn’s disease and ulcerative colitis is likely to spur the growth of the inflammatory bowel disease treatment market.

What Segment Types Define the Inflammatory Bowel Disease Treatment Market Structure?

The inflammatory bowel disease treatment market covered in this report is segmented –

1) By Drug Class: Aminosalicylates, Corticosteroids, TNF inhibitors, IL inhibitors, Anti-integrin, JAK inhibitors, Other Drug Classes

2) By Type: Crohn’s Disease, Ulcerative Colitis

3) By Route Of Administration: Oral, Injectable

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Aminosalicylates: Mesalamine, Sulfasalazine, Balsalazide

2) By Corticosteroids: Prednisone, Budesonide, Hydrocortisone

3) By TNF Inhibitors: Infliximab, Adalimumab, Certolizumab pegol

4) By IL Inhibitors: Ustekinumab, Guselkumab

5) By Anti-Integrin: Vedolizumab, Natalizumab

6) By JAK Inhibitors: Tofacitinib, Filgotinib

7) By Other Drug Classes: Antibiotics, Immunosuppressants, Other Novel Therapies

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=6704&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Inflammatory Bowel Disease Treatment Market?

North America was the largest region in the inflammatory bowel disease treatment market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inflammatory bowel disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Long-Term Trends Are Transforming the Competitive Landscape of the Inflammatory Bowel Disease Treatment Market?

Rising technology improvements are becoming a notable trend in the market for treatment of inflammatory bowel disease. Key players in this field are shifting towards the use of AI-driven registries to obtain a competitive advantage. This was evidenced in May 2024, when Verantos, a Californian company specializing in real-world evidence (RWE), introduced their Inflammatory Bowel Disease Pragmatic Registry. This registry uses cutting-edge artificial intelligence to craft quality real-world evidence (RWE) for Crohn’s disease and ulcerative colitis. Its aim is to support the creation of potent therapies by making available a vast dataset that contains over 3 billion points of data on patient care. It provides an opportunity for biopharma researchers to dig deep into the severity of diseases, the efficacy of treatments, and clinical results by harnessing both structured and unstructured data from digital health records.

View the full report here:

https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

What Is the Definition of the Inflammatory Bowel Disease Treatment Market?

Inflammatory bowel disease treatment refers to anti-inflammatory medications that are commonly used to treat mild to moderate ulcerative colitis. Aminosalicylates such as mesalamine (Delzicol, Rowasa, and other brands), balsalazide (Colazal), and olsalazine are anti-inflammatories (Dipentum).

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6704

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2124 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Inflammatory Bowel Disease Treatment Market?

The growing prevalence of Crohn’s disease and ulcerative colitis is significantly driving the inflammatory bowel disease treatment market. These conditions cause inflammation in the digestive tract, requiring treatment to manage symptoms and prevent complications. According to the U.S. National Library of Medicine, 1.6 million Americans suffer from inflammatory bowel disease, with 70,000 new diagnoses each year. As these conditions increase, so will the demand for treatment options, fueling the growth of the inflammatory bowel disease treatment market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6704&type=smp

What is the Predicted Annual Growth Rate of theInflammatory Bowel Disease Treatment Market Impact Industry Trends by 2034?

The inflammatory bowel disease treatment market has shown significant growth in recent years. It will rise from $25.26 billion in 2024 to $27.45 billion in 2025, at a compound annual growth rate (CAGR) of 8.6%. The growth is driven by the increasing prevalence of inflammatory bowel disease, rising demand for biologics and immunomodulators, advancements in treatment options, the aging population, and greater awareness about the disease.

The inflammatory bowel disease treatment market is projected to grow rapidly, reaching $40.27 billion by 2029 at a CAGR of 10.1%. Key factors include increased R&D investment, growing biosimilar demand, higher incidence of IBD, personalized medicine, and precision treatments. Trends include more product launches, personalized dosing plans, telemedicine integration, microbiome-based therapies, and value-based care models.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6704

What Are the Key Market Innovations in theInflammatory Bowel Disease Treatment Market Over the Coming Years?

Technological advancement is a significant trend in the inflammatory bowel disease treatment market. Companies are focusing on leveraging AI-driven registries to enhance their competitive edge. For example, in May 2024, Verantos, a California-based real-world evidence company, launched the Inflammatory Bowel Disease Pragmatic Registry. This AI-powered registry aims to provide comprehensive datasets on ulcerative colitis and Crohn’s disease, enabling researchers to develop effective therapies based on real-world data, including over 3 billion data points from electronic health records.

Who Are the Top Companies Driving Innovation and Growth in theInflammatory Bowel Disease Treatment Market?

Major companies operating in the inflammatory bowel disease treatment market include AbbVie Inc., Biogen Inc., Johnson & Johnson, Amgen Inc., Advanced Gastroenterology and Surgery Associates P. A., Atlanta Gastroenterology Associates LLC, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Cedars-Sinai Medical Center, Celgene Corporation, Cleveland Clinic Foundation, Digestive Disease Associates of Rockland P. C., Eli Lilly and Company, Gastrointestinal Specialists Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Illinois Gastroenterology Group LLC, The Johns Hopkins Hospital Inc., Massachusetts General Hospital, Mayo Clinic, Merck & Co. Inc., Mount Sinai Health System Inc., Novartis International AG, Pfizer Inc., F. Hoffmann-La Roche Ltd, Takeda Pharmaceutical Company Limited, Texas Digestive Disease Consultants P. A., The Oregon Clinic – Gastroenterology West P. C., Salix Pharmaceuticals Inc., Vifor Pharma AG, Zydus Pharmaceuticals (USA) Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

Which Key Market Segments Comprise the Inflammatory Bowel Disease Treatment Market and Drive Its Revenue Growth?

The inflammatory bowel disease treatment market covered in this report is segmented –

1) By Drug Class: Aminosalicylates, Corticosteroids, TNF inhibitors, IL inhibitors, Anti-integrin, JAK inhibitors, Other Drug Classes

2) By Type: Crohn’s Disease, Ulcerative Colitis

3) By Route Of Administration: Oral, Injectable

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Aminosalicylates: Mesalamine, Sulfasalazine, Balsalazide

2) By Corticosteroids: Prednisone, Budesonide, Hydrocortisone

3) By TNF Inhibitors: Infliximab, Adalimumab, Certolizumab pegol

4) By IL Inhibitors: Ustekinumab, Guselkumab

5) By Anti-Integrin: Vedolizumab, Natalizumab

6) By JAK Inhibitors: Tofacitinib, Filgotinib

7) By Other Drug Classes: Antibiotics, Immunosuppressants, Other Novel Therapies

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=6704&type=smp

Which Regions Are Emerging as Leaders in the Inflammatory Bowel Disease Treatment Market?

North America was the largest region in the inflammatory bowel disease treatment market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inflammatory bowel disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Reports Similar to the Gobal Inflammatory Bowel Disease Treatment Maret 2025, By The Business Research Company:

Microbiome Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/microbiomes-global-market-report

Digestive Enzymes Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/digestive-enzyme-global-market-report

C-Reactive Protein Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/c-reactive-protein-testing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

2124 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Inflammatory Bowel Disease Treatment Market?

The growing prevalence of Crohn’s disease and ulcerative colitis is significantly driving the inflammatory bowel disease treatment market. These conditions cause inflammation in the digestive tract, requiring treatment to manage symptoms and prevent complications. According to the U.S. National Library of Medicine, 1.6 million Americans suffer from inflammatory bowel disease, with 70,000 new diagnoses each year. As these conditions increase, so will the demand for treatment options, fueling the growth of the inflammatory bowel disease treatment market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6704&type=smp

What is the Predicted Annual Growth Rate of theInflammatory Bowel Disease Treatment Market Impact Industry Trends by 2034?

The inflammatory bowel disease treatment market has shown significant growth in recent years. It will rise from $25.26 billion in 2024 to $27.45 billion in 2025, at a compound annual growth rate (CAGR) of 8.6%. The growth is driven by the increasing prevalence of inflammatory bowel disease, rising demand for biologics and immunomodulators, advancements in treatment options, the aging population, and greater awareness about the disease.

The inflammatory bowel disease treatment market is projected to grow rapidly, reaching $40.27 billion by 2029 at a CAGR of 10.1%. Key factors include increased R&D investment, growing biosimilar demand, higher incidence of IBD, personalized medicine, and precision treatments. Trends include more product launches, personalized dosing plans, telemedicine integration, microbiome-based therapies, and value-based care models.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6704

What Are the Key Market Innovations in theInflammatory Bowel Disease Treatment Market Over the Coming Years?

Technological advancement is a significant trend in the inflammatory bowel disease treatment market. Companies are focusing on leveraging AI-driven registries to enhance their competitive edge. For example, in May 2024, Verantos, a California-based real-world evidence company, launched the Inflammatory Bowel Disease Pragmatic Registry. This AI-powered registry aims to provide comprehensive datasets on ulcerative colitis and Crohn’s disease, enabling researchers to develop effective therapies based on real-world data, including over 3 billion data points from electronic health records.

Who Are the Top Companies Driving Innovation and Growth in theInflammatory Bowel Disease Treatment Market?

Major companies operating in the inflammatory bowel disease treatment market include AbbVie Inc., Biogen Inc., Johnson & Johnson, Amgen Inc., Advanced Gastroenterology and Surgery Associates P. A., Atlanta Gastroenterology Associates LLC, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Cedars-Sinai Medical Center, Celgene Corporation, Cleveland Clinic Foundation, Digestive Disease Associates of Rockland P. C., Eli Lilly and Company, Gastrointestinal Specialists Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Illinois Gastroenterology Group LLC, The Johns Hopkins Hospital Inc., Massachusetts General Hospital, Mayo Clinic, Merck & Co. Inc., Mount Sinai Health System Inc., Novartis International AG, Pfizer Inc., F. Hoffmann-La Roche Ltd, Takeda Pharmaceutical Company Limited, Texas Digestive Disease Consultants P. A., The Oregon Clinic – Gastroenterology West P. C., Salix Pharmaceuticals Inc., Vifor Pharma AG, Zydus Pharmaceuticals (USA) Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

Which Key Market Segments Comprise the Inflammatory Bowel Disease Treatment Market and Drive Its Revenue Growth?

The inflammatory bowel disease treatment market covered in this report is segmented –

1) By Drug Class: Aminosalicylates, Corticosteroids, TNF inhibitors, IL inhibitors, Anti-integrin, JAK inhibitors, Other Drug Classes

2) By Type: Crohn’s Disease, Ulcerative Colitis

3) By Route Of Administration: Oral, Injectable

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Aminosalicylates: Mesalamine, Sulfasalazine, Balsalazide

2) By Corticosteroids: Prednisone, Budesonide, Hydrocortisone

3) By TNF Inhibitors: Infliximab, Adalimumab, Certolizumab pegol

4) By IL Inhibitors: Ustekinumab, Guselkumab

5) By Anti-Integrin: Vedolizumab, Natalizumab

6) By JAK Inhibitors: Tofacitinib, Filgotinib

7) By Other Drug Classes: Antibiotics, Immunosuppressants, Other Novel Therapies

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=6704&type=smp

Which Regions Are Emerging as Leaders in the Inflammatory Bowel Disease Treatment Market?

North America was the largest region in the inflammatory bowel disease treatment market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inflammatory bowel disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Reports Similar to the Gobal Inflammatory Bowel Disease Treatment Maret 2025, By The Business Research Company:

Microbiome Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/microbiomes-global-market-report

Digestive Enzymes Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/digestive-enzyme-global-market-report

C-Reactive Protein Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/c-reactive-protein-testing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the inflammatory bowel disease treatment market grown in recent years?

The market size for treatment of inflammatory bowel disease has seen substantial expansion in the past few years. The projection is that it will escalate from $25.26 billion in 2024 to $27.45 billion in 2025, with a compound annual growth rate (CAGR) of 8.6%. The surge during the historic period can be accredited to factors such as a surge in cases of inflammatory bowel disease, escalating demand for biologics and immunomodulators, advancements in treatment modalities, an aging population, and heightened cognizance about the disease.

How is the inflammatory bowel disease treatment market size expected to evolve during the forecast period?

In the coming years, the market size for the treatment of inflammatory bowel disease is predicted to witness a swift expansion. By 2029, it is expected to reach a staggering value of $40.27 billion, progressing at a compound annual growth rate (CAGR) of 10.1%. Several factors can be credited for the projected growth during this period including the increasing investment in research and development, a surging demand for biosimilars and personalized medicine, higher incidences of inflammatory bowel disease in emerging markets and the application of precision medicine in treating IBD. Upcoming trends anticipated during this forecast period comprise an augmenting number of product launches and approvals, customization of treatment regimes and dosages for managing IBD, the employment of telemedicine to remotely monitor IBD patients, introduction of microbiome-based therapies for treating IBD, and the integration of value-based care models in the treatment of IBD.

Get your inflammatory bowel disease treatment market report here!

https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

Which key drivers are propelling the inflammatory bowel disease treatment market’s growth?

The surge in cases of Crohn’s disease and ulcerative colitis is a significant factor propelling the growth of the market for inflammatory bowel disease treatment. These two conditions are forms of inflammatory bowel diseases (IBD) which lead to inflammation and ulceration (sores) in the digestive system. The increase in instances of Crohn’s disease and ulcerative colitis is anticipated to enhance the demand for therapeutic solutions for inflammatory bowel disease, as they are commonly employed to decrease inflammation within the bowel and mitigate and avert health-related complications. For instance, research conducted in the United States National Library of Medicine in March 2022 reports that approximately 1.6 million Americans currently live with inflammatory bowel disease (either Crohn’s disease or ulcerative colitis), and about 70,000 fresh instances of IBD are identified annually in the USA. Therefore, the escalating occurrence of Crohn’s disease and ulcerative colitis is projected to fuel the progression of the inflammatory bowel disease treatment market.

What are the market segments in the inflammatory bowel disease treatment industry?

The inflammatory bowel disease treatment market covered in this report is segmented –

1) By Drug Class: Aminosalicylates, Corticosteroids, TNF inhibitors, IL inhibitors, Anti-integrin, JAK inhibitors, Other Drug Classes

2) By Type: Crohn’s Disease, Ulcerative Colitis

3) By Route Of Administration: Oral, Injectable

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Aminosalicylates: Mesalamine, Sulfasalazine, Balsalazide

2) By Corticosteroids: Prednisone, Budesonide, Hydrocortisone

3) By TNF Inhibitors: Infliximab, Adalimumab, Certolizumab pegol

4) By IL Inhibitors: Ustekinumab, Guselkumab

5) By Anti-Integrin: Vedolizumab, Natalizumab

6) By JAK Inhibitors: Tofacitinib, Filgotinib

7) By Other Drug Classes: Antibiotics, Immunosuppressants, Other Novel Therapies

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6704&type=smp

Which leading companies are shaping the growth of the inflammatory bowel disease treatment market?

Major companies operating in the inflammatory bowel disease treatment market include AbbVie Inc., Biogen Inc., Johnson & Johnson, Amgen Inc., Advanced Gastroenterology and Surgery Associates P. A., Atlanta Gastroenterology Associates LLC, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Cedars-Sinai Medical Center, Celgene Corporation, Cleveland Clinic Foundation, Digestive Disease Associates of Rockland P. C., Eli Lilly and Company, Gastrointestinal Specialists Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Illinois Gastroenterology Group LLC, The Johns Hopkins Hospital Inc., Massachusetts General Hospital, Mayo Clinic, Merck & Co. Inc., Mount Sinai Health System Inc., Novartis International AG, Pfizer Inc., F. Hoffmann-La Roche Ltd, Takeda Pharmaceutical Company Limited, Texas Digestive Disease Consultants P. A., The Oregon Clinic – Gastroenterology West P. C., Salix Pharmaceuticals Inc., Vifor Pharma AG, Zydus Pharmaceuticals (USA) Inc.

What key trends are currently impacting the inflammatory bowel disease treatment market’s development?

The inflammatory bowel disease treatment market is increasingly witnessing the influence of technology as a key growing trend. Major entities in the market are leveraging AI-based registry to seek a competitive advantage. For instance, in May 2024, Verantos, a company based in California specializing in real-world evidence (RWE), unveiled the Inflammatory Bowel Disease Pragmatic Registry. This is powered by state-of-the-art artificial intelligence and provides high-quality real-world evidence for ulcerative colitis and Crohn’s disease. The objective of this registry is to aid in developing effective therapies by offering an expansive dataset of over 3 billion data points regarding patient care. It grants biopharma researchers the ability to delve deeper into aspects like disease severity, treatment efficacy, and clinical outcomes by using both organized and unorganized data from electronic healthcare records.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6704

Which geographic areas are influencing the growth of the inflammatory bowel disease treatment market?

North America was the largest region in the inflammatory bowel disease treatment market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inflammatory bowel disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Microbiome Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/microbiomes-global-market-report

Digestive Enzymes Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/digestive-enzyme-global-market-report

C-Reactive Protein Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/c-reactive-protein-testing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Growth Opportunities are Expected to Drive the Inflammatory Bowel Disease Treatment Market’s CAGR Through 2034?

In the past few years, the market size for inflammatory bowel disease treatment has seen a robust growth. It is set to expand from $25.26 billion in 2024 to approximately $27.45 billion in 2025, at a Compound Annual Growth Rate (CAGR) of 8.6%. This growth during the historical period can be ascribed to factors like increased occurrence of inflammatory bowel disease, the rising demand for biologics and immunomodulators, advancements in the treatment alternatives, an increasing elderly population, and heightened awareness about the disease.

The market for treatment of inflammatory bowel disease is projected to experience swift expansion in the coming years, with its value expected to reach $40.27 billion in 2029, signifying a compound annual growth rate (CAGR) of 10.1%. The anticipated growth over the forecast period can be linked to incremental investment in research and development of new treatment techniques, burgeoning demand for biosimilars, an increase in instances of inflammatory bowel diseases in developing markets, a surge in demand for customized medication, and integration of precision medicine in IBD treatment protocols. Major trends to look out for within this period include a rise in the number of product launches and approvals, the application of personalized dosing and treatment strategies in managing IBD, the utilization of telemedicine for distant monitoring of IBD patients, the exploration of microbiome-rooted therapies for IBD, and the adoption of value-based care schemas in IBD treatment.

What Industry-Specific Factors Are Fueling the Growth of the inflammatory bowel disease treatment Market?

The escalating incidences of Crohn’s disease and ulcerative colitis are notably fueling the development of the inflammatory bowel disease treatment marketplace. Crohn’s disease and ulcerative colitis, known as types of inflammatory bowel diseases (IBD), trigger inflammation and the formation of ulcers (sores) in the digestive systems. The mounting occurrences of these diseases are presumed to elevate the demand for inflammatory bowel disease therapies, which are broadly practiced to lessen bowel inflammation and mitigate and avert medical complications. As indicated by research published in the United States National Library of Medicine in March 2022, an American medical library, roughly 1.6 million Americans are currently living with inflammatory bowel disease (Crohn’s disease or ulcerative colitis), with about 70,000 fresh instances of IBD identified annually in the USA. As such, the growing incidences of Crohn’s disease and ulcerative colitis are anticipated to propel the growth of the inflammatory bowel disease treatment marketplace.

Request Your Free Inflammatory Bowel Disease Treatment Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=6704&type=smp

Who Are the Major Companies Shaping the Competitive Landscape of the Inflammatory Bowel Disease Treatment Market?

Major companies operating in the inflammatory bowel disease treatment market include:

• AbbVie Inc._x000D_

• Biogen Inc._x000D_

• Johnson & Johnson_x000D_

• Amgen Inc._x000D_

• Advanced Gastroenterology and Surgery Associates P. A._x000D_

What Are the Key Emerging Trends in the Inflammatory Bowel Disease Treatment Market for the Next Decade?

In the inflammatory bowel disease treatment market, technological progression is becoming an increasingly prevalent trend. Major players in the market are turning their focus to AI-powered registries to maintain a competitive edge. For example, in May 2024, Verantos, a firm based in California specializing in real-world evidence (RWE), introduced its Inflammatory Bowel Disease Pragmatic Registry, utilising sophisticated artificial intelligence to create high-quality real-world evidence for Crohn’s disease and ulcerative colitis. The registry aims to promote the creation of effective treatments by presenting a comprehensive dataset that includes over 3 billion data points on patient care. By utilising both structured and unstructured data from electronic health records, it lets biopharma researchers obtain precise assessments of disease severity, treatment efficacy and clinical outcomes.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

What Are the Strategic Segments Comprising the Inflammatory Bowel Disease Treatment Market and Their Growth Contributions?

The inflammatory bowel disease treatment market covered in this report is segmented –

1) By Drug Class: Aminosalicylates, Corticosteroids, TNF inhibitors, IL inhibitors, Anti-integrin, JAK inhibitors, Other Drug Classes

2) By Type: Crohn’s Disease, Ulcerative Colitis

3) By Route Of Administration: Oral, Injectable

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Aminosalicylates: Mesalamine, Sulfasalazine, Balsalazide

2) By Corticosteroids: Prednisone, Budesonide, Hydrocortisone

3) By TNF Inhibitors: Infliximab, Adalimumab, Certolizumab pegol

4) By IL Inhibitors: Ustekinumab, Guselkumab

5) By Anti-Integrin: Vedolizumab, Natalizumab

6) By JAK Inhibitors: Tofacitinib, Filgotinib

7) By Other Drug Classes: Antibiotics, Immunosuppressants, Other Novel Therapies

Which Regions Are Making a Mark in the Inflammatory Bowel Disease Treatment Market Growth?

North America was the largest region in the inflammatory bowel disease treatment market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inflammatory bowel disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Defining Aspects of the Inflammatory Bowel Disease Treatment Market Landscape?

Inflammatory bowel disease treatment refers to anti-inflammatory medications that are commonly used to treat mild to moderate ulcerative colitis. Aminosalicylates such as mesalamine (Delzicol, Rowasa, and other brands), balsalazide (Colazal), and olsalazine are anti-inflammatories (Dipentum).

Browse Through More Similar Reports By The Business Research Company:

Microbiome Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/microbiomes-global-market-report

Digestive Enzymes Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/digestive-enzyme-global-market-report

C-Reactive Protein Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/c-reactive-protein-testing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: